IPO Details
| IPO Date | 8 to 10 Sep, 2026 |
| Listing Date | Wed, Sep 16, 2026 |
| Face Value | ₹ 2 per share |
| Price Band | ₹643 to ₹676 |
| Lot Size | 22 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 73,96,437 shares (agg. up to ₹ 500 Cr) |
| Fresh Issue | 11,83,431 shares (agg. up to ₹ 80 Cr) |
| Offer for Sale | 62,13,006 shares of ₹ 2 (agg. up to ₹ 420 Cr) |
| Share Holding Pre Issue | 5,80,00,000 shares |
| Share Holding Post Issue | 5,91,83,431 shares |
IPO Important Dates
| IPO Open | Tue, Sep 8, 2026 |
| IPO Close | Thu, Sep 10, 2026 |
| Allotment | Fri, Sep 11, 2026 |
| Refund | Tue, Sep 15, 2026 |
| Credit of Shares | Tue, Sep 15, 2026 |
| Listing | Wed, Sep 16, 2026 |
IPO Lot Size
| Retail (Min) | 1 | 22 | ₹14,872 |
| Retail (Max) | 13 | 286 | ₹1,93,336 |
| S-HNI (Min) | 14 | 308 | ₹2,08,208 |
| S-HNI (Max) | 67 | 1,474 | ₹9,96,424 |
| B-HNI (Min) | 68 | 1,496 | ₹10,11,296 |
Financial Information
| Assets | 839.28 | 723.09 | 626.36 |
| Total Income | 1,237.85 | 1,015.54 | 887.56 |
| Profit After Tax | 83.12 | 43.57 | 18.13 |
| EBITDA | 139.32 | 87.77 | 60.53 |
| NET Worth | 448.51 | 367.46 | 325.84 |
| Reserves and Surplus | 436.91 | 355.87 | 314.24 |
| Total Borrowing | 110.06 | 101.05 | 82.07 |
Key Performance Indicator
| ROE | 20.37% |
| ROCE | 22.43% |
| Debt/Equity | 0.19 |
| RoNW | 18.53% |
| PAT Margin | 6.74% |
| EBITDA Margin | 11.30% |
| NAV | 77.33 |
Information about company
Incorporated in 1992, Prasol Chemicals operates in the specialty chemicals industry. The company manufactures over 150 specialty chemicals, including acetone-based, phosphorous-based, and other complex chemicals. Its product portfolio includes 21 acetone-based chemicals, 53 phosphorous-based chemicals, and 76 other specialty chemicals (e.g. surfactants, esters, acids).
The products serve 5 major industries, including Performance chemicals (like lubricant and mining additives), paint, inks, construction, and adhesives (PICA), pharmaceuticals, agrochemicals, and home and personal care.
Manufacturing Facility: The company operates two manufacturing facility in Khopoli across 1,20,604 sq. m., Mahad across 1,19,423 sq. mt with an aggregate capacity of 98,644 MT per year.
Key customers: Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science, Gharda Chemicals, Croda India, Supriya Lifescience, Yasho Industries, etc. As of July 31, 2026, the company served 1600 customers and exports to 69 countries.
It is certified as a 3 Star Export House by the Indian government and have a strong global distribution network across APAC, North and South America, and Europe.
Competitive Strengths:
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
#: Issue Objects
1: Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the company
2: General Corporate Purposes
: Total
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App
Day Wise GMP
IPO Reservation
| QIB | Not more than 50% of the Offer |
| Retail | Not less than 35% of the Offer |
| NII | Not less than 15% of the offer |
